Effects of a bifid triple viable capsule on inflammatory factors and intestinal barrier function in children with abdominal infection. [PDF]
Yan X, Zhong X, Zhang X.
europepmc +1 more source
Unravelling three-way interactions between <i>Clostridioides difficile</i>, microbiota and the host. [PDF]
Bywater-Brenna KK, Unnikrishnan M.
europepmc +1 more source
The Effect of Climate Change on Emergence and Evolution of Zoonotic Diseases in Asia
ABSTRACT As the climate of Asia changes under the influence of global warming, the incidence and spatial distribution of known zoonoses will evolve, and new zoonoses are expected to emerge as a result of greater exposure to organisms which currently occur only in wildlife.
Roger S. Morris, Masako Wada
wiley +1 more source
Bacterial pathogens in Jiangxi poultry (2023-2024): Prevalence and antimicrobial resistance profiles. [PDF]
Tan MF +9 more
europepmc +1 more source
Homeostasis of Gut Microbiota Protects against Susceptibility to Fungal Pneumonia
Fungal pneumonia induces inflammation, shown by heightened IL‐6, IL‐1β, TNF‐α levels and a growth in Staphylococcus in the alveolar flora. The gut microbiota, acting through the gut‐lung axis via blood, impacts fungal pneumonia susceptibility by altering lung metabolism and inflammatory responses.
Jian Ji +12 more
wiley +1 more source
Conventional and molecular identification of Iranian Clostridia species associated with animal infection. [PDF]
Abdolmohammadi Khiav L +2 more
europepmc +1 more source
Cardiovascular disease (CVD) and cancer are leading causes of death worldwide, with overlapping risk factors and pathophysiological mechanisms. This review explores shared pathways, including metabolic dysregulation, chronic inflammation, and gut microbiome alterations, highlighting dual‐benefit strategies such as lifestyle modifications and repurposed
Shihan Xiang +6 more
wiley +1 more source
Optimizing Antibiotic Choice, Administration, and Duration in NSTI Treatment. [PDF]
Howell D +3 more
europepmc +1 more source
Clinical discovery and the proposed underlying mechanism by how P. johnsonii ameliorated metabolic disorders. Abstract The gut bacterium Parabacteroides spp. is increasingly recognized for its therapeutic potential in treating metabolic disorders. However, the role of Parabacteroides johnsonii in metabolic disorders is never reported.
Yimeng Chen +9 more
wiley +1 more source
Microbiota-Based Therapies for Recurrent Clostridium difficile Infection: A Systematic Review of Their Efficacy and Safety. [PDF]
Weerakoon S +6 more
europepmc +1 more source

